STOCK TITAN

[Form 4] Ardent Health, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

David Raynor Byers, Senior Vice President & Chief Accounting Officer of Ardent Health, Inc. (ARDT), reported a routine disposition of common stock on 09/25/2025. The filing shows 524 shares were disposed under Code F (withholding to pay taxes upon vesting of restricted stock units) at a reported price equal to the closing stock price on 09/25/2025 of $13.19. After the withholding, Mr. Byers beneficially owns 111,791 shares directly. The Form 4 was signed by an attorney-in-fact on 09/30/2025.

David Raynor Byers, Senior Vice President e Chief Accounting Officer di Ardent Health, Inc. (ARDT), ha riferito una disposizione routinaria di azioni comuni il 25/09/2025. La pratica mostra che sono state dispose 524 azioni sotto il Codice F (ritenzione per pagare le tasse al vesting delle unità di azioni restritte) ad un prezzo riportato pari al prezzo di chiusura delle azioni del 25/09/2025 di 13,19 $. Dopo la ritenzione, il signor Byers detiene direttamente 111.791 azioni. Il modulo 4 è stato firmato da un procuratore in fact il 30/09/2025.

David Raynor Byers, vicepresidente senior y director de contabilidad de Ardent Health, Inc. (ARDT), reportó una disposición rutinaria de acciones comunes el 25/09/2025. El escrito muestra que se disponían 524 acciones bajo el Código F (retenida para pagar impuestos al vesting de las unidades de acciones restringidas) a un precio reportado igual al precio de cierre de las acciones el 25/09/2025 de $13.19. Después de la retención, el señor Byers posee directamente 111,791 acciones. El Formulario 4 fue firmado por un apoderado el 30/09/2025.

데이비드 레이나르 바이어스(Ardent Health, Inc.의 수석 부사장 겸 최고 회계 책임자)는 2025년 9월 25일 일반 주식의 일상적 처분을 보고했습니다. 서류에 따르면 524주가 F 코드하에 처분되었으며(제한 주식단의 vesting 시 세금을 납부하기 위한 원천징수), 보고된 가격은 2025년 9월 25일 종가인 13.19달러와 같았습니다. 원천징수 후 Byers 씨는 직접 111,791주를 유익하게 소유합니다. Form 4는 2025년 9월 30일에 사실대리인이 서명했습니다.

David Raynor Byers, vice-président principal et directeur de la comptabilité chez Ardent Health, Inc. (ARDT), a signalé une disposition routinière d’actions ordinaires le 25/09/2025. Le dossier indique que 524 actions ont été cédées sous le Code F (retenue pour payer les impôts au vesting des unités d’actions restreintes) à un prix déclaré équivalent au cours de clôture du 25/09/2025 de 13,19 $. Après la retenue, M. Byers détient directement 111 791 actions. Le Formulaire 4 a été signé par un mandataire le 30/09/2025.

David Raynor Byers, Senior Vice President und Chief Accounting Officer von Ardent Health, Inc. (ARDT), meldete am 25.09.2025 eine routinemäßige Veräußerung von Stammaktien. Die Einreichung zeigt, dass 524 Aktien unter Code F (mit Steuerabzug zur Begleichung der Steuern beim Vesting von Restricted Stock Units) zu einem gemeldeten Preis von 13,19 USD veräußert wurden. Nach dem Abzug besitzt Herr Byers direkt 111.791 Aktien. Das Formular 4 wurde am 30.09.2025 von einem Bevollmächtigten unterschrieben.

ديفيد راينور بايرز، نائب رئيس أول ومدير المحاسبة في أرْدنْت هيلث، إنك (ARDT)، قد أبلغ عن تصرف روتيني في الأسهم العادية في 25/09/2025. يظهر الملف أن 524 سهماً تم التصرف بها بموجب الرمز F (اقتطاع للضرائب عند vesting وحدات الأسهم المقيدة) بسعر مُبلغ عنه يساوي سعر إغلاق السهم في 25/09/2025 وهو 13.19 دولار. بعد الاقتطاع، يمتلك السيد بايرز مباشرة 111,791 سهماً بفائدة. تم توقيع النموذج 4 من قبل وكيل قانوني في 30/09/2025.

David Raynor Byers,Ardent Health, Inc.(ARDT)的高级副总裁兼首席会计官,报告于2025年9月25日进行了普通股的常规处置。 备案显示在F代码下处置了524股(从限制性股票单位 vesting 时的税款扣缴),披露价格等同于2025年9月25日的收盘价,即13.19美元。扣税后,Byers先生直接持有111,791股。Form 4于2025年9月30日由一名代理律师签署。

Positive
  • Continued direct ownership of 111,791 shares after the withholding event
  • Transaction is routine (Code F), indicating tax withholding for vested restricted stock units rather than an open-market sale
Negative
  • None.

Insights

TL;DR: Routine tax-withholding sale of vested RSUs; maintains sizeable direct ownership—no material governance concerns shown.

The transaction is coded as Code F, indicating shares were withheld to satisfy tax obligations upon RSU vesting rather than an open-market sale. Such transactions are standard compensation-related mechanics and do not signal a change in executive control or a distribution event. The post-transaction direct beneficial ownership of 111,791 shares remains substantial in absolute terms though materiality relative to outstanding shares is not provided in the filing.

TL;DR: Small-scale disposition for tax withholding; price listed is the reported closing price of $13.19 on the transaction date.

The Form 4 documents a disposal of 524 shares at $13.19 reflecting tax-withholding on vested restricted stock units. This is a routine, non-dispositive trading event for valuation or signaling purposes. No derivative transactions or additional purchases were reported. The filing is informational and unlikely to be market-moving on its own.

David Raynor Byers, Senior Vice President e Chief Accounting Officer di Ardent Health, Inc. (ARDT), ha riferito una disposizione routinaria di azioni comuni il 25/09/2025. La pratica mostra che sono state dispose 524 azioni sotto il Codice F (ritenzione per pagare le tasse al vesting delle unità di azioni restritte) ad un prezzo riportato pari al prezzo di chiusura delle azioni del 25/09/2025 di 13,19 $. Dopo la ritenzione, il signor Byers detiene direttamente 111.791 azioni. Il modulo 4 è stato firmato da un procuratore in fact il 30/09/2025.

David Raynor Byers, vicepresidente senior y director de contabilidad de Ardent Health, Inc. (ARDT), reportó una disposición rutinaria de acciones comunes el 25/09/2025. El escrito muestra que se disponían 524 acciones bajo el Código F (retenida para pagar impuestos al vesting de las unidades de acciones restringidas) a un precio reportado igual al precio de cierre de las acciones el 25/09/2025 de $13.19. Después de la retención, el señor Byers posee directamente 111,791 acciones. El Formulario 4 fue firmado por un apoderado el 30/09/2025.

데이비드 레이나르 바이어스(Ardent Health, Inc.의 수석 부사장 겸 최고 회계 책임자)는 2025년 9월 25일 일반 주식의 일상적 처분을 보고했습니다. 서류에 따르면 524주가 F 코드하에 처분되었으며(제한 주식단의 vesting 시 세금을 납부하기 위한 원천징수), 보고된 가격은 2025년 9월 25일 종가인 13.19달러와 같았습니다. 원천징수 후 Byers 씨는 직접 111,791주를 유익하게 소유합니다. Form 4는 2025년 9월 30일에 사실대리인이 서명했습니다.

David Raynor Byers, vice-président principal et directeur de la comptabilité chez Ardent Health, Inc. (ARDT), a signalé une disposition routinière d’actions ordinaires le 25/09/2025. Le dossier indique que 524 actions ont été cédées sous le Code F (retenue pour payer les impôts au vesting des unités d’actions restreintes) à un prix déclaré équivalent au cours de clôture du 25/09/2025 de 13,19 $. Après la retenue, M. Byers détient directement 111 791 actions. Le Formulaire 4 a été signé par un mandataire le 30/09/2025.

David Raynor Byers, Senior Vice President und Chief Accounting Officer von Ardent Health, Inc. (ARDT), meldete am 25.09.2025 eine routinemäßige Veräußerung von Stammaktien. Die Einreichung zeigt, dass 524 Aktien unter Code F (mit Steuerabzug zur Begleichung der Steuern beim Vesting von Restricted Stock Units) zu einem gemeldeten Preis von 13,19 USD veräußert wurden. Nach dem Abzug besitzt Herr Byers direkt 111.791 Aktien. Das Formular 4 wurde am 30.09.2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Byers David Raynor

(Last) (First) (Middle)
340 SEVEN SPRINGS WAY, SUITE 100

(Street)
BRENTWOOD TN 37027

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP & Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/25/2025 F 524(1) D $13.19(2) 111,791 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
2. Represents the closing price of the common stock of the Issuer on September 25, 2025.
Remarks:
/s/ Stephen C. Petrovich, Attorney-in-Fact 09/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did David Raynor Byers report on Form 4 for ARDT?

He reported a disposition of 524 shares on 09/25/2025 coded as Code F (shares withheld to pay taxes on vested RSUs).

At what price were the shares disposed according to the Form 4?

The filing reports a price of $13.19, which the filer states is the closing price on 09/25/2025.

How many Ardent Health (ARDT) shares does the reporting person own after the transaction?

The Form 4 shows 111,791 shares beneficially owned following the reported transaction.

What does transaction code F mean on this Form 4?

In this filing Code F denotes shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units, as stated in the Explanation of Responses.

When was the Form 4 signed and filed?

The document was signed by an attorney-in-fact on 09/30/2025 according to the signature block.
ARDENT HEALTH PARTNERS INC

NYSE:ARDT

ARDT Rankings

ARDT Latest News

ARDT Latest SEC Filings

ARDT Stock Data

1.90B
110.01M
23.13%
73.84%
1.52%
Medical Care Facilities
Services-general Medical & Surgical Hospitals, Nec
Link
United States
BRENTWOOD